Immune-directed gene therapeutic development for alzheimer's, prion, and parkinson's diseases

Journal of Neuroimmune Pharmacology

Volumn 4, Issue 3, 2009, Pages 298-308

  Maguire Zeiss, Kathleen A ^a   Federoff, Howard J ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Active vaccination; Alzheimer's disease; Parkinson's disease; Passive vaccination; Prion disease; Single chain antibody

Indexed keywords

ALPHA SYNUCLEIN; ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; AMYLOID BETA PROTEIN[1-42]; CHEMOKINE; CHOLINESTERASE INHIBITOR; CYTOKINE; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOLOGICAL ADJUVANT; PARVOVIRUS VECTOR; PRION PROTEIN ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TETANUS TOXIN; TETANUS TOXIN FRAGMENT C; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; AGGRESSION; ALZHEIMER DISEASE; AMNESIA; APOPTOSIS; BRADYKINESIA; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL EXPANSION; CELL MIGRATION; CELL POPULATION; CELLULAR IMMUNITY; CLINICAL FEATURE; DELUSION; DOPAMINERGIC NERVE CELL; DRUG SAFETY; DRUG TARGETING; DRUG TOLERABILITY; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOMODULATION; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PASSIVE IMMUNIZATION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; REVIEW; RIGIDITY; T LYMPHOCYTE ACTIVATION; TREMOR; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ALZHEIMER DISEASE; ANTIBODIES; GENE THERAPY; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOTHERAPY; PARKINSON DISEASE; PRION DISEASES;

EID: 68749100991     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-008-9133-3     Document Type: Review

References (110)

1. BJ Bacskai ST Kajdasz ME McLellan D Games P Seubert D Schenk BT Hyman 2002 Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy J Neurosci 22 7873 7878
2. F Bard C Cannon R Barbour RL Burke D Games H Grajeda T Guido K Hu J Huang K Johnson-Wood K Khan D Kholodenko M Lee I Lieberburg R Motter M Nguyen F Soriano N Vasquez K Weiss B Welch P Seubert D Schenk T Yednock 2000 Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease Nat Med 6 916 919
3. DM Barten CF Albright 2008 Therapeutic strategies for Alzheimer's disease Mol Neurobiol 37 2-3 171 186
4. RT Bartus RLd Dean B Beer AS Lippa 1982 The cholinergic hypothesis of geriatric memory dysfunction Science 217 408 414
5. AJ Bayer R Bullock RW Jones D Wilkinson KR Paterson L Jenkins SB Millais S Donoghue 2005 Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD Neurology 64 94 101
6. KM Bishop EK Hofer A Mehta A Ramirez L Sun M Tuszynski RT Bartus 2008 Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons Exp Neurol 211 574 584
7. S Bombois CA Maurage M Gompel V Deramecourt MA Mackowiak-Cordoliani RS Black R Lavielle A Delacourte F Pasquier 2007 Absence of beta-amyloid deposits after immunization in Alzheimer disease with Lewy body dementia Arch Neurol 64 583 587
8. NM Bonini BI Giasson 2005 Snaring the function of alpha-synuclein Cell 123 359 361
9. WJ Bowers MA Mastrangelo HA Stanley AE Casey LJ Milo Jr HJ Federoff 2005 HSV amplicon-mediated Abeta vaccination in Tg2576 mice: differential antigen-specific immune responses Neurobiol Aging 26 393 407
10. DL Brody DM Holtzman 2008 Active and passive immunotherapy for neurodegenerative disorders Annu Rev Neurosci 31 175 193
11. C Burger OS Gorbatyuk MJ Velardo CS Peden P Williams S Zolotukhin PJ Reier RJ Mandel N Muzyczka 2004 Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system Mol Ther 10 302 317
12. R Cappai SL Leck DJ Tew NA Williamson DP Smith D Galatis RA Sharples CC Curtain FE Ali RA Cherny JG Culvenor SP Bottomley CL Masters KJ Barnham AF Hill 2005 Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway FASEB J 19 1377 1379
13. M Cavazzana-Calvo S Hacein-Bey G de Saint Basile F Gross E Yvon P Nusbaum F Selz C Hue S Certain JL Casanova P Bousso FL Deist A Fischer 2000 Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Science 288 669 672 (Pubitemid 30241569)
14. CN Cearley LH Vandenberghe MK Parente ER Carnish JM Wilson JH Wolfe 2008 Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain Mol Ther 16 10 1710 1718
15. MA Chishti DS Yang C Janus AL Phinney P Horne J Pearson R Strome N Zuker J Loukides J French S Turner G Lozza M Grilli S Kunicki C Morissette J Paquette F Gervais C Bergeron PE Fraser GA Carlson PS George-Hyslop D Westaway 2001 Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695 J Biol Chem 276 21562 21570
16. KA Conway SJ Lee JC Rochet TT Ding RE Williamson PT Lansbury Jr 2000 Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy Proc Natl Acad Sci U S A 97 571 576
17. KA Conway JC Rochet RM Bieganski PT Lansbury Jr 2001 Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein Adduct Science 294 1346 1349
18. D Cuchet C Potel J Thomas AL Epstein 2007 HSV-1 amplicon vectors: a promising and versatile tool for gene delivery Expert Opin Biol Ther 7 975 995
19. RB DeMattos KR Bales DJ Cummins JC Dodart SM Paul DM Holtzman 2001 Peripheral anti-Abeta antibody alters CNS and plasma Abeta clearance and decreases brain Abeta burden in a mouse model of Alzheimer's disease Proc Natl Acad Sci U S A 3 3
20. JD Ding J Lin BE Mace R Herrmann P Sullivan C Bowes Rickman 2008 Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model Vision Res 48 339 345
21. JC Dodart KR Bales KS Gannon SJ Greene RB DeMattos C Mathis CA DeLong S Wu X Wu DM Holtzman SM Paul 2002 Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model Nat Neurosci 5 452 457
22. G Donofrio FL Heppner M Polymenidou C Musahl A Aguzzi 2005 Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies J Virol 79 8330 8338
23. OM El-Agnaf SA Salem KE Paleologou MD Curran MJ Gibson JA Court MG Schlossmacher D Allsop 2006 Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease FASEB J 20 419 425
24. SS El-Amouri H Zhu J Yu R Marr IM Verma MS Kindy 2008 Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease Am J Pathol 172 1342 1354
25. S Emadi R Liu B Yuan P Schulz C McAllister Y Lyubchenko A Messer MR Sierks 2004 Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments Biochemistry 43 2871 2878
26. S Emadi H Barkhordarian MS Wang P Schulz MR Sierks 2007 Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity J Mol Biol 368 1132 1144
27. M Enari E Flechsig C Weissmann 2001 Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody Proc Natl Acad Sci U S A 98 9295 9299
28. HJ Federoff WJ Bowers 2005 Immune shaping and the development of Alzheimer's disease vaccines Sci Aging Knowledge Environ 2005 46 pe35
29. AL Fink 2006 The aggregation and fibrillation of alpha-synuclein Acc Chem Res 39 628 634
30. W Fischer K Wictorin A Bjorklund LR Williams S Varon FH Gage 1987 Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor Nature 329 65 68
31. ME Frazer JE Hughes MA Mastrangelo JL Tibbens HJ Federoff WJ Bowers 2008 Reduced pathology and improved behavioral performance in Alzheimer's disease mice vaccinated with HSV amplicons expressing amyloid-beta and interleukin-4 Mol Ther 16 845 853
32. H Garren 2008 A DNA vaccine for multiple sclerosis Expert Opin Biol Ther 8 1539 1550
33. H Garren WH Robinson E Krasulova E Havrdova C Nadj K Selmaj J Losy I Nadj EW Radue BA Kidd J Gianettoni K Tersini PJ Utz F Valone L Steinman 2008 Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis Ann Neurol 63 611 620
34. JM George H Jin WS Woods DF Clayton 1995 Characterization of a novel protein regulated during the critical period for song learning in the zebra finch Neuron 15 361 372
35. S Gilman M Koller RS Black L Jenkins SG Griffith NC Fox L Eisner L Kirby MB Rovira F Forette JM Orgogozo 2005 Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial Neurology 64 1553 1562
36. J Grutzendler JC Morris 2001 Cholinesterase inhibitors for Alzheimer's disease Drugs 61 41 52
37. S Hacein-Bey-Abina C von Kalle M Schmidt F Le Deist N Wulffraat E McIntyre I Radford JL Villeval CC Fraser M Cavazzana-Calvo A Fischer 2003 A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency N Engl J Med 348 255 256
38. CG Haidaris J Malone LA Sherrill JM Bliss AA Gaspari RA Insel MA Sullivan 2001 Recombinant human antibody single chain variable fragments reactive with Candida albicans surface antigens J Immunol Methods 257 185 202
39. J Hardy 1997 Amyloid, the presenilins and Alzheimer's disease Trends Neurosci 20 154 159
40. J Hardy D Allsop 1991 Amyloid deposition as the central event in the aetiology of Alzheimer's disease Trends Pharmacol Sci 12 383 388
41. J Hardy K Duff KG Hardy J Perez-Tur M Hutton 1998 Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau Nat Neurosci 1 355 358
42. F Hefti 1986 Nerve growth factor (NGF) promotes survival of septal cholinergic neurons after fimbrial transection J Neurosci 6 2155 2162
43. F Hefti A Dravid J Hartikka 1984 Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions Brain Res 293 305 311
44. K Hsiao P Chapman S Nilsen C Eckman Y Harigaya S Younkin F Yang G Cole 1996 Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 274 99 102
45. C Janus J Pearson J McLaurin PM Mathews Y Jiang SD Schmidt MA Chishti P Horne D Heslin J French HT Mount RA Nixon M Mercken C Bergeron PE Fraser P St George-Hyslop D Westaway 2000 A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease Nature 408 979 982
46. WE Klunk JC Price CA Mathis ND Tsopelas BJ Lopresti SK Ziolko W Bi JA Hoge AD Cohen MD Ikonomovic JA Saxton BE Snitz DA Pollen M Moonis CF Lippa JM Swearer KA Johnson DM Rentz AJ Fischman HJ Aizenstein ST DeKosky 2007 Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees J Neurosci 27 6174 6184
47. RE Kontermann 2004 Intrabodies as therapeutic agents Methods 34 163 170
48. LA Kotilinek B Bacskai M Westerman T Kawarabayashi L Younkin BT Hyman S Younkin KH Ashe 2002 Reversible memory loss in a mouse transgenic model of Alzheimer's disease J Neurosci 22 6331 6335
49. LF Kromer 1987 Nerve growth factor treatment after brain injury prevents neuronal death Science 235 214 216
50. M Kutubuddin HJ Federoff PM Challita-Eid M Halterman B Day M Atkinson V Planelles JD Rosenblatt 1999 Eradication of pre-established lymphoma using herpes simplex virus amplicon vectors Blood 93 643 654
51. HJ Lee S Patel SJ Lee 2005 Intravesicular localization and exocytosis of alpha-synuclein and its aggregates J Neurosci 25 6016 6024
52. R Levi-Montalcini V Hamburger 1951 Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo J Exp Zool 116 321 362
53. J Li M Zhu AB Manning-Bog DA Di Monte AL Fink 2004 Dopamine and L-dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease FASEB J 18 962 964
54. CH Lu CJ Lee P Kind 1994 Immune responses of young mice to pneumococcal type 9V polysaccharide-tetanus toxoid conjugate Infect Immun 62 2754 2760
55. SM Lynch C Zhou A Messer 2008 An scFv intrabody against the nonamyloid component of alpha-synuclein reduces intracellular aggregation and toxicity J Mol Biol 377 136 147
56. KA Maguire-Zeiss HJ Federoff 2003 Convergent pathobiologic model of Parkinson's disease Ann N Y Acad Sci 991 152 166
57. KA Maguire-Zeiss HJ Federoff 2004 Safety of viral vectors for neurological gene therapies Curr Opin Mol Ther 6 473 481
58. KA Maguire-Zeiss WJ Bowers HJ Federoff 2001 HSV vector-mediated gene delivery to the central nervous system Curr Opin Mol Ther 3 482 490
59. KA Maguire-Zeiss DW Short HJ Federoff 2005 Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease? Brain Res Mol Brain Res 134 18 23
60. KA Maguire-Zeiss CI Wang E Yehling MA Sullivan DW Short X Su G Gouzer LA Henricksen CA Wuertzer HJ Federoff 2006 Identification of human alpha-synuclein specific single chain antibodies Biochem Biophys Res Commun 349 1198 1205
61. KA Maguire-Zeiss TR Mhyre HJ Federoff 2007 Gazing into the future: Parkinson's disease gene therapeutics to modify natural history Exp Neurol 209 1 101 113
62. J Malone MA Sullivan 1996 Analysis of antibody selection by phage display utilizing anti-phenobarbital antibodies J Mol Recognit 9 738 745
63. PL McGeer EG McGeer 2008 Glial reactions in Parkinson's disease Mov Disord 23 474 483
64. PL McGeer S Itagaki BE Boyes EG McGeer 1988 Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains Neurology 38 1285 1291
65. H Mochizuki T Yasuda MM Mouradian 2008 Advances in gene therapy for movement disorders Neurotherapeutics 5 260 269
66. D Morgan DM Diamond PE Gottschall KE Ugen C Dickey J Hardy K Duff P Jantzen G DiCarlo D Wilcock K Connor J Hatcher C Hope M Gordon GW Arendash 2000 A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease Nature 408 982 985
67. CE Moussa F Mahmoodian Y Tomita A Sidhu 2008 Dopamine differentially induces aggregation of A53T mutant and wild type alpha-synuclein: insights into the protein chemistry of Parkinson's disease Biochem Biophys Res Commun 365 833 839
68. NN Nalivaeva LR Fisk ND Belyaev AJ Turner 2008 Amyloid-degrading enzymes as therapeutic targets in Alzheimer's disease Curr Alzheimer Res 5 212 224
69. JA Nicoll D Wilkinson C Holmes P Steart H Markham RO Weller 2003 Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report Nat Med 9 448 452
70. S Oddo A Caccamo M Kitazawa BP Tseng FM LaFerla 2003 Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease Neurobiol Aging 24 1063 1070
71. JA Olschowka WJ Bowers SD Hurley MA Mastrangelo HJ Federoff 2003 Helper-free HSV-1 amplicons elicit a markedly less robust innate immune response in the CNS Mol Ther 7 218 227
72. Y Ouchi E Yoshikawa Y Sekine M Futatsubashi T Kanno T Ogusu T Torizuka 2005 Microglial activation and dopamine terminal loss in early Parkinson's disease Ann Neurol 57 168 175
73. E Paxinou Q Chen M Weisse BI Giasson EH Norris SM Rueter JQ Trojanowski VM Lee H Ischiropoulos 2001 Induction of alpha-synuclein aggregation by intracellular nitrative insult J Neurosci 21 8053 8061
74. D Peretz RA Williamson K Kaneko J Vergara E Leclerc G Schmitt-Ulms IR Mehlhorn G Legname MR Wormald PM Rudd RA Dwek DR Burton SB Prusiner 2001 Antibodies inhibit prion propagation and clear cell cultures of prion infectivity Nature 412 739 743
75. RG Perez TG Hastings 2004 Could a loss of alpha-synuclein function put dopaminergic neurons at risk? J Neurochem 89 1318 1324
76. I Petrushina A Ghochikyan M Mktrichyan G Mamikonyan N Movsesyan H Davtyan A Patel E Head DH Cribbs MG Agadjanyan 2007 Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric Abeta species in amyloid precursor protein transgenic mice J Neurosci 27 12721 12731
77. M Pfeifer S Boncristiano L Bondolfi A Stalder T Deller M Staufenbiel PM Mathews M Jucker 2002 Cerebral hemorrhage after passive anti-Abeta immunotherapy Science 298 1379
78. SB Prusiner 2001 Shattuck lecture-neurodegenerative diseases and prions N Engl J Med 344 1516 1526
79. TH Rabbitts K Bucher G Chung G Grutz A Warren Y Yamada 1999 The effect of chromosomal translocations in acute leukemias: the LMO2 paradigm in transcription and development Cancer Res 59 1794s 1798s
80. JE Rabinowitz RJ Samulski 2000 Building a better vector: the manipulation of AAV virions Virology 278 301 308
81. MM Racke LI Boone DL Hepburn M Parsadainian MT Bryan DK Ness KS Piroozi WH Jordan DD Brown WP Hoffman DM Holtzman KR Bales BD Gitter PC May SM Paul RB DeMattos 2005 Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta J Neurosci 25 629 636
82. JC Rochet TF Outeiro KA Conway TT Ding MJ Volles HA Lashuel RM Bieganski SL Lindquist PT Lansbury 2004 Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's disease J Mol Neurosci 23 23 34
83. K Santos DA Simon E Conway WJ Bowers S Mitra TH Foster A Lugade EM Lord HJ Federoff S Dewhurst JG Frelinger 2007 Spatial and temporal expression of herpes simplex virus type 1 amplicon-encoded genes: implications for their use as immunization vectors Hum Gene Ther 18 93 105
84. D Schenk R Barbour W Dunn G Gordon H Grajeda T Guido K Hu J Huang K Johnson-Wood K Khan D Kholodenko M Lee Z Liao I Lieberburg R Motter L Mutter F Soriano G Shopp N Vasquez C Vandevert S Walker M Wogulis T Yednock D Games P Seubert 1999 Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 173 177
85. DJ Selkoe 1996 Amyloid beta-protein and the genetics of Alzheimer's disease J Biol Chem 271 18295 18298
86. Z Shevtsova JM Malik U Michel M Bahr S Kugler 2005 Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo Exp Physiol 90 53 59
87. A Sidhu C Wersinger P Vernier 2004 Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse? FASEB J 18 637 647
88. A Sidhu C Wersinger P Vernier 2004 alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease FEBS Lett 565 1 5
89. MV Sofroniew NP Galletly O Isacson CN Svendsen 1990 Survival of adult basal forebrain cholinergic neurons after loss of target neurons Science 247 338 342
90. JM Souza BI Giasson Q Chen VM Lee H Ischiropoulos 2000 Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies J Biol Chem 275 18344 18349
91. MG Spillantini ML Schmidt VM Lee JQ Trojanowski R Jakes M Goedert 1997 Alpha-synuclein in Lewy bodies Nature 388 839 840
92. MG Spillantini RA Crowther R Jakes M Hasegawa M Goedert 1998 alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies Proc Natl Acad Sci U S A 95 6469 6473 (Pubitemid 28249037)
93. Su X, Maguire-Zeiss KA, Giuliano R, Prifti L, Venkatesh K, Federoff HJ (2008) Synuclein activates microglia in a model of Parkinson's disease. Neurobiol Aging 29:1690-1701
94. JM Taymans LH Vandenberghe CV Haute I Thiry CM Deroose L Mortelmans JM Wilson Z Debyser V Baekelandt 2007 Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain Hum Gene Ther 18 195 206
95. T Tokuda SA Salem D Allsop T Mizuno M Nakagawa MM Qureshi JJ Locascio MG Schlossmacher OM El-Agnaf 2006 Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease Biochem Biophys Res Commun 349 162 166
96. KA Tolba WJ Bowers SP Hilchey MW Halterman DF Howard RE Giuliano HJ Federoff JD Rosenblatt 2001 Development of herpes simplex virus-1 amplicon-based immunotherapy for chronic lymphocytic leukemia Blood 98 287 295
97. MH Tuszynski 2007 Nerve growth factor gene therapy in Alzheimer disease Alzheimer Dis Assoc Disord 21 179 189
98. MH Tuszynski FH Gage 1990 Potential use of neurotrophic agents in the treatment of neurodegenerative disorders Acta Neurobiol Exp (Wars) 50 311 322
99. A Ulusoy T Bjorklund S Hermening D Kirik 2008 In vivo gene delivery for development of mammalian models for Parkinson's disease Exp Neurol 209 89 100
100. VN Uversky J Li AL Fink 2001 Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular link between Parkinson's disease and heavy metal exposure J Biol Chem 276 44284 44296
101. VN Uversky J Li AL Fink 2001 Evidence for a partially folded intermediate in alpha-synuclein fibril formation J Biol Chem 276 10737 10744
102. VN Uversky HJ Lee J Li AL Fink SJ Lee 2001 Stabilization of partially folded conformation during alpha-synuclein oligomerization in both purified and cytosolic preparations J Biol Chem 276 43495 43498
103. MJ Volles SJ Lee JC Rochet MD Shtilerman TT Ding JC Kessler PT Lansbury Jr 2001 Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease Biochemistry 40 7812 7819
104. DM Wilcock SK Munireddy A Rosenthal KE Ugen MN Gordon D Morgan 2004 Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration Neurobiol Dis 15 11 20
105. DM Wilcock A Rojiani A Rosenthal S Subbarao MJ Freeman MN Gordon D Morgan 2004 Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage J Neuroinflammation 1 24
106. LR Williams S Varon GM Peterson K Wictorin W Fischer A Bjorklund FH Gage 1986 Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection Proc Natl Acad Sci U S A 83 9231 9235
107. MS Wolfe 2008 Gamma-secretase inhibition and modulation for Alzheimer's disease Curr Alzheimer Res 5 158 164
108. CA Wuertzer MA Sullivan X Qiu HJ Federoff 2008 CNS delivery of vectored prion-specific single-chain antibodies delays disease onset Mol Ther 16 481 486
109. BA Yankner T Lu P Loerch 2008 The aging brain Annu Rev Pathol 3 41 66
110. C Zhou S Emadi MR Sierks A Messer 2004 A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein Mol Ther 10 1023 1031